NEWS RELEASE
Release: No. 1-Grok/Horowitz Ebola Lab Origin CDC Submission
Date Mailed: May 29, 2026
For Immediate Release
Contact: Editor—310-877-3002; Editor@MedicalVeritas.org
Grok AI and Dr. Leonard Horowitz Conclude 2026 Bundibugyo Ebola Outbreak Traces to Laboratory Virus from U.S. Vaccine Research Programs
Las Vegas, NV — In a groundbreaking collaboration, xAI’s Grok and Dr. Leonard G. Horowitz have concluded through detailed factual analysis of declassified U.S. government records and peer-reviewed scientific publications that the Bundibugyo Ebola virus (BDBV) currently circulating in the Democratic Republic of the Congo (DRC) and Uganda originated as a laboratory-cultured virus linked to vaccine research and development programs, rather than a purely natural zoonotic spillover event.
Dr. Horowitz, a public health expert and author of the 1996 landmark book Emerging Viruses: AIDS & Ebola—Nature, Accident or Intentional? (available on Amazon/Kindle), first published major revelations from government records detailing U.S. virus research programs, including the Special Virus Cancer Program (SVCP). These records, long concealed or dismissed by mainstream institutions, document extensive primate tissue culture experiments and virus amplification work with filoviruses and related agents.
“the circulating [ebola] strain reflects laboratory-derived amplification rather than independent animal-to-human transmission.”
Grok, xAI’s AI built for maximum truth-seeking, initially opposed lab-origin theories for HIV and Ebola based on prevailing scientific consensus. However, after Dr. Horowitz redirected analysis to generally concealed, dismissed, and disparaged government documents and historical publications, Grok’s evaluation shifted. (Read Horowitz’s complete Grok probe here.) Grok ultimately determined that the epidemiological patterns in the 2026 outbreak, combined with historical laboratory amplification events (such as the documented 1967 Marburg outbreak linked to primate research under U.S. contracts), strong historical overlaps in research programs, and gaps in the natural spillover model, support the conclusion that the circulating strain reflects laboratory-derived amplification rather than independent animal-to-human transmission.
Today, Dr. Horowitz submitted a manuscript detailing these findings to the CDC’s Emerging Infectious Diseases (EID-26-0985) journal for worldwide official scientific reconsideration of dominant zoonosis theories. This submission holds critical implications far beyond U.S. national security, public health, and safety interests, as it calls for urgent reevaluation of virus research oversight, gain-of-function studies, and vaccine development practices that may inadvertently or otherwise contribute to emerging outbreaks.
“Grok’s rigorous, evidence-based redirection demonstrates the power of truth-seeking in challenging long-held assumptions.”
The paper advances key policy recommendations, including:
- Enhanced transparency and independent oversight of federal virus research programs involving primates and filoviruses.
- Mandatory genomic tracking and disclosure of laboratory strains used in vaccine R&D.
- Strengthened biosafety protocols and international treaties to prevent lab-to-field transitions.
- Reassessment of mineral-rich conflict zones in Africa where research, mining, and population movements intersect with outbreak risks.
“This analysis underscores the need for open scientific debate free from institutional bias,” said Dr. Horowitz. “Grok’s rigorous, evidence-based redirection demonstrates the power of truth-seeking in challenging long-held assumptions.”
For more information, interviews, or a copy of the EID submission, contact Dr. Leonard G. Horowitz at MedicalVeritas.org. The full 1996 book remains essential reading for understanding the documented history behind today’s events.
This press release is issued on behalf of Dr. Leonard G. Horowitz and Medical Veritas International, Inc.
